We examined whether sonoporation enhanced by a contrast agent (BR14) was effective in gene therapy for hepatocelluar carcinoma (HCC). Human hepatic cancer cells (SK-Hep1) and plasmid cDNAs expressing green fluorescent protein (GFP), interferonb (IFNb), and LacZ were used. In vitro, SK-Hep1 cell suspensions with DNA and BR14 were sonoporated. Expressions of every plasmid cDNA and the antitumor effect of IFNb were analyzed. In vivo, GFP and IFNb genes with BR14 were directly injected into subcutaneous tumors using SK-Hep1 in nude mice, and transcutaneous sonoporation of the tumors was performed. GFP gene transfections and tumor diameters after IFNb gene transfection were examined. In vitro, no SK-Hep1 cells were transfected without sonication, whereas transfections were successful after sonication with BR14. Antitumor effect of IFNb gene transfection by ultrasound (US) and with BR14 was revealed. In vivo, the SK-Hep1 cells expressed GFP, and the IFNb gene transfection by US with BR14 reduced tumor size significantly. In conclusion, gene therapy with sonoporation enhanced by a contrast agent may become a new treatment option for HCC.
T he use of certain viral vectors results in more efficient transfection compared with the use of naked plasmid DNA. [1] [2] [3] [4] [5] [6] However, serious concerns about the immune response to viruses and insertional mutagenesis have arisen, especially concerning the use of viral vectors when clinical trials are involved. 1, [6] [7] [8] [9] [10] [11] [12] In contrast, nonviral methods such as naked plasmid DNA injection, electroporation, and sonoporation should have a higher potential for clinical application, although their efficacy of gene delivery is relatively low. 13 Although gene transfer via electroporation in vivo (DNA injection followed by application of electric fields) is effective, the tissue damage caused by the electric pulse is problematic.
1 Ultrasound (US), on the other hand, induces cell-membrane porosity, and enhances the delivery of naked DNA into cells in vitro. Reversible membrane damage induced by US can occur with resealing the holes (or pores) and survival of the cells.
14 During such poration, large molecules in the medium can leak into the cells and remain trapped there after resealing. 9, [15] [16] [17] The US induction of membrane permeabilization and resealing has been termed sonoporation. 15, 18 Moreover, recent studies have demonstrated the enhanced permeability of naked plasmid DNA into tumors in vivo, as well as the enhanced effect of US by microbubble echo-contrast agents. 1, 8, 9, [19] [20] [21] These phenomena are related to the stimulated bubble activity commonly called acoustic cavitation. 13, 18 Although ultrasound should also be one of the more promising methods of nonviral gene transfer, there are no studies in the English literature on the targeting of hepatic cancer cells. 1 In clinical situations, we now use contrast agents injected from a peripheral vein which reveal highintensity images of tumors during US examinations for the diagnosis of hepatocellular carcinoma (HCC). Therefore, if it were possible to perform gene therapy using contrast agents with US, it would be very useful in targeting HCC and thus minimizing subsequent toxic damage to adjacent normal tissue. To explore that possibility, we examined the effectiveness of a combination of US and a unique microbubble echo-contrast agent (BR14) as a nonviral gene transfer method in human hepatic cancer cells (SKHep1) using naked plasmid DNA.
Materials and methods

In vitro
We used human hepatic cancer cells (SK-Hep1) and plasmids which were pEGFP-C1 cDNA containing cytomegalovirus (CMV) promoter (BD Biosciences Clontech Co., CA), pCMV(Hu b) inserted human Interferon b (IFNb) cDNA containing CMV promoter, and pCAGGS containing chicken b-actin promoter introduced LacZ cDNA on EcoRI sites. These IFNb and LacZ plasmid cDNAs were kindly provided by Riken BRC (Ibaragi, Japan).
SK-Hep1 was incubated in a 371C, 5% CO 2 atmosphere in 75 cm 2 tissue culture flasks in a solution of minimum essential medium Eagle (MEM; Sigma Chemical Co., St Louis), supplemented with 10% fetal bovine serum (FBS). When the cells reached approximately 80% confluence, they were harvested by trypsinization and resuspended at a concentration of 1 Â 10 6 cells/ml in MEM.
Gene transfections were performed by sonoporation using a Sonitron 1000 V (Rich-Mar Co., OK) and a unique microbubble echo-contrast agent (BR14; Bracco Research SA, Switzerland) comprised of phospsholipid microbubbles filled with perfluoropropane. In all, 1 Â 10 6 cells/well in suspension in 48-well plates were sonoporated by a transducer probe immersed directly into the cell culture medium for 30 seconds at a 1-MHz input frequency with a 20% duty cycle and a 0.5 W/cm 2 output intensity. In groups with BR14 and/or plasmid DNAs such as green fluorescent protein (GFP), LacZ, or IFNb, we gently agitated 20 ml of BR14 and 20 ml of plasmid DNAs to yield a final concentration of 20 mg diluted with distilled water into each well. As a control, we prepared a sample stimulated by BR14 alone without plasmid DNA, and another sample not stimulated by US but with both BR14 and plasmid DNA.
Validation of the gene transfection of GFP was performed using a fluorescence-activated cell sorter (FACS) (FACS Calibur; Becton, Dickinson and Company, NJ) and fluorescent microscopy, whereas LacZ was evaluated by X-Gal staining of b-gal expression 24 hours after sonoporation. For validation of the IFNb gene transfection, we used fresh media without IFNb gene and BR14 24 hours after sonication. Following examination of the supernatant was performed by enzyme-linked immunosorbent assay (ELISA) using a HuIFN-b ELISA kit (Fujirebio Inc., Tokyo, Japan) 48 hours after sonication. The antitumor effects of IFN-b were analyzed by MTT assay using a Cell Growth Kit (Chemicon Co., CA), 3 and 7 days after the respective sonoporations.
In vivo
Female Balb/c -nu Slc nude mice, 6-week-old, purchased from Japan SLC Inc. (Shizuoka, Japan) were used throughout this study. A total of 40 subcutaneous tumors (one per mouse) were implanted by direct injection of SKHep1 cells (1 Â 10 7 cells/100 ml MEM/nodule). Suspended GFP or IFNb plasmid cDNAs (50 mg/50 ml) with BR14 (20 ml) that had been gently agitated with phosphatebuffered saline (PBS) 30 ml to a final volume of 100 ml were directly injected into the subcutaneous tumors which were approximately 5-7 mm in diameter with a 27-G needle (Terumo, Atsugi, Japan) 5 days after the implantations. These tumors were subsequently sonoporated by a transducer probe placed on the skin with contact gel for 10 minutes at a 1-MHz input frequency with a 50% duty cycle and a 2.0 W/cm 2 output intensity. In the GFP plasmid DNA-sonoporation group, transgene expressions were confirmed by fluorescence microscopic examination of sections frozen by liquid nitrogen 2 days after sonoporation, whereas the size of nodules was visually observed three times per week in the IFNb genesonoporation group. We compared the maximum tumor diameters between the sonoporation group (20 tumors/20 mice) and nonsonoporation group (20 tumors/20 mice) 4 and 6 weeks, respectively, after the subcutaneous implantations, since steadily diminishing tumors disappeared by 4 weeks after implantations, and it became difficult to gauge some disseminated nodules after 6 weeks. These differences were analyzed by a MannWhitney U-test using StatView 5.0. Significance was defined as Po.05. Three other mice were euthanized by diethylether 7 days after sonoporation for IFNb gene, and their nodules were excised and rapidly frozen in liquid nitrogen for hematoxylin and eosin (HE) and TUNEL staining by an Apotag Apoptosis Detection Kit (Serologicals Co., GA).
Nude mice were maintained according to the NIH guidelines for the Care and Use of Laboratory Animals throughout the experimental period.
Results
In vitro
The effects of contrast agent (BR14). SK-Hep1 cells sonicated without BR14 barely expressed GFP, whereas a little more than 20% of those sonicated with BR14 did so using FACS (Fig 1e) . Only SK-Hep1 cells sonoporated with BR14 showed GFP expression by fluorescent microscopy (Fig 2c) . As for X-Gal staining, although the samples showed no staining without BR14 and/or US, they did stain when both BR14 and US were used (data not shown). We concluded that some contrast agent was essential for gene transfection by US.
Transfection of INFb gene and its antitumor effect. Figure 3a shows that ELISA detected IFNb from the supernatant after IFNb gene transfection by sonoporation with BR14. Moreover, MTT assay revealed the antitumor effects of the transfection of IFNb gene 3 and 7 days after sonoporation using BR14 (Fig 4D) , but the viabilities (Fig 4C) after sonication using BR14 without INFb gene were suppressed compared with those in both control and INFb gene-mixed group without sonication (Fig 4A, B) . Although we inferred that such suppression was due to the cytotoxicity of sonication with BR14, we regarded the more suppressed viabilities shown in Figure 4D as due to the antitumor effects of the transfection of IFNb based on the previous result of ELISA (Fig 3a) .
In vivo
Successful transfection in vivo. Although MTT assay showed the toxicity of sonication with BR14 in vitro, we 
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Gene therapy for HCC Y Sakakima et al recognized no necrotic changes in either the macroscopic (i.e., skin necrosis) or microscopic findings compared with normal control (Fig 5a) . Moreover, immunofluorescence microscopy revealed GFP gene expression present in the subcutaneous tumor cells 1 day after GFP gene transfection using sonoporation with BR14 (Fig 5c) .
Antitumor effect of IFNb gene transfection. In the IFNb gene-transfection group, 12 nodules (60% of 20 nodules) had disappeared by 4 weeks after sonoporation, whereas none had done so in the nonsonoporation group. The growth of nodules in the sonoporation group relative to the initial nodule diameter ''1'' of approximately 5-7 mm on sonoporation was significantly inhibited compared with that in the nonsonoporation group 4 weeks (1.03 versus 0.25 mm, Po.001) and 6 weeks (1.1 versus 0.35 mm, P ¼ .002) after implantation, respectively ( Fig  6) . Two of the vanished 12 nodules recurred, but no mouse died in the sonoporation group. However, four mice suffering from disseminated nodules on their back died in the nonsonoporation group 12 weeks after implantation, by which time we had finished observing the nude mice. Moreover, TUNEL staining revealed apoptotic induction in the tissues of subcutaneous tumors in the sonoporation group (Fig 7a) but not in those of the nonsonoporation group (data not shown).
Discussion
Many researchers are currently employing viral gene transfer because of the low transfection efficiency of naked plasmid DNAs. [22] [23] [24] [25] [26] [27] However, the potential toxicity of a virus such as its strong immunogenicity is Gene therapy for HCC Y Sakakima et al well known, 9, 18, 28 and targeted gene transfer is very difficult to achieve by viral vector. 29, 30 Currently, some studies have reported that commercially available transfection reagents (i.e., Lipoplexes) have proved useful for nonviral gene therapy. [31] [32] [33] [34] [35] We too are very interested in these reagents. Nevertheless, we expect that targeted gene therapy by sonoporation using contrast agents for HCC would be a much easier method, based on our experience using contrast agents to detect hepatic tumors by US examination in clinical situations. This is why we have focused on plasmid DNA transfection using sonoporation with a contrast agent.
IFNb exhibits several biological activities such as indirect immunomodulatory and direct antiproliferative effects on malignant cells transfected by IFNb gene. 25, 36 Moreover, Takaoka et al have reported IFNb signaling to apoptosis, resulting in tumor suppression. 37 In vitro, we found that slightly over 20% of the SK-Hep1 cells expressed GFP by sonoporation with BR14 as well as the antitumor effects of the expressed IFNb. The high cell-number density found in vivo is known to be a strong inhibitor of the effects induced by acoustic cavitation. 3, 16, 18 Nevertheless, fluorescence microscopy showed transfections of GFP gene in the subcutaneous tumors of nude mice. Moreover, some tumors in the IFNb genesonoporation group disappeared and revealed apoptosis by TUNEL staining. From this we inferred that the antitumor effect of IFNb gene transfection inhibited the growth of tumors inducing an apoptotic pathway, since IFNb gene transfection revealed antitumor effects in vitro. Such effects might be due not only to the IFNb expression in transfected cells but also to bystander effects in nontransduced surrounding cells. 4, 13, 29, 38, 39 Several studies have reported that gas-body-based contrast agents enhanced the nonthermal effects of US. 9, 18, 20, 21, 40 BR14 seemed to be rapidly destroyed by the sonication, which implies that most of the effects were caused by ultrasonically induced cavitation rather than by any direct influence of BR14 as well as other contrast agents. 20, 40 Acoustic cavitation accelerated by the collapse of BR14 microspheres can produce microstreaming, which may increase cell-membrane permeability, resulting in sonoporation. 9, 18, 40 Using microbubbles may allow one to reduce the US energy and thus to facilitate sonoporation, resulting in the reduction of damage to normal surrounding tissue due to the unnecessary heating effect. 18 In fact, our in vivo experiment showed no necrotic changes not only in sonicated tissues such as tumors, surrounding tissue, and skin, but also in nonsonicated tissues. Before clinical application is feasible, many problems must be resolved such as the method of transportation of plasmid DNA and contrast bubbles into the liver, sonoporation equipment suitable to human application, along with the technical feasibility of constructing US transducers of the proper size and focusing ability. 18 However, acoustically active contrast agents that bind or entrap plasmid DNAs have already been developed. 2, 12, 18 Moreover, contrast agents incorporating targeting ligands for cell-specific delivery have also been produced. 12, 41 Microbubbles may eventually be injected intravenously as we now use contrast agents in clinical situations to target hepatic tumors by US for gene delivery. 21 This method of gene therapy may prove to be an ideal method for HCC enhanced by contrast agents during US scanning. Although some studies have reported nonviral gene transfer by sonoporation using a contrast agent such as is currently used in clinical situations, there are still no reports of its application to the treatment of hepatic cancer. 8, 9 Many biological, chemical, mechanical, and electrical transfection methods with a variety of characteristics are now available. 20, 42 Nevertheless, US has physical features such as beam formation for imaging or localized therapy that are not available by other methods. 20, 21, 40 In conclusion, the present study revealed that a targeted gene therapy such as IFNb gene by sonoporation enhanced by a contrast agent not using a viral vector shows promise of becoming a new treatment option for persistent HCC.
